Wow – as of 2020, the United States Center for Disease Control (CDC) has confirmed that over 10% of the U.S. population is currently living with diabetes, making it one…
Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD) in which excess fat is stored in the liver. This buildup of fat is not caused by…
Sign up today and be the first to hear about new studies!
Preferred Research Partners is comprised of a network of clinical research investigators in multiple therapeutic areas who are dedicated to providing quality care to their research & clinical populations while producing quality data for sponsors & CROs.
(501) 553-9987
Who qualifies for this research study?
Men ages 45-80 with Low Testosterone (hypogonadism) at an increased risk or history of
Cardiovascular Disease. The clinical site will be able to provide more information about additional
requirements for study participation.
Where are the research sites?
There are approximately 400 centers in the United States that are helping to conduct this study.
When will I know if I qualify for a study?
If you pass this initial screener, a member of a study doctor’s staff will contact you – they will ask
you more questions to further assess if you should participate in this study. If they believe that you
should be considered, you will be asked to schedule an appointment at the doctor’s office or clinic
for further evaluations. When you go to the doctor’s office, the study doctor and his/her team
conduct study related examinations and tests to see if you can be enrolled into this study.
How long will my participation in the study last, if I qualify?
Your participation may last for up to approximately 5 years. During this time, the study doctors will
monitor your health and progress.
What is the purpose of these research studies?
The purpose of this study is to evaluate the safety and effectiveness of an investigational
medication for Low Testosterone (hypogonadism) with an increased risk or history of
Cardiovascular Disease.
Who qualifies for this research study?
Men ages 45-80 with Low Testosterone (hypogonadism) at an increased risk or history of
Cardiovascular Disease. The clinical site will be able to provide more information about additional
requirements for study participation.
Where are the research sites?
There are approximately 400 centers in the United States that are helping to conduct this study.
When will I know if I qualify for a study?
If you pass this initial screener, a member of a study doctor’s staff will contact you – they will ask
you more questions to further assess if you should participate in this study. If they believe that you
should be considered, you will be asked to schedule an appointment at the doctor’s office or clinic
for further evaluations. When you go to the doctor’s office, the study doctor and his/her team
conduct study related examinations and tests to see if you can be enrolled into this study.
How long will my participation in the study last, if I qualify?
Your participation may last for up to approximately 5 years. During this time, the study doctors will
monitor your health and progress.
What is the purpose of these research studies?
The purpose of this study is to evaluate the safety and effectiveness of an investigational
medication for Low Testosterone (hypogonadism) with an increased risk or history of
Cardiovascular Disease.
Learn more about the study here.
Learn more about the study here.
